Drugs like Ozempic and Wegovy may provide a surprising, life-saving benefit for the youngest patients taking these diabetes and weight loss medications.

Researchers said the drugs don’t appear to raise the risk of suicidal thoughts or actions for young people but also urged ...

Weight loss drugs like Ozempic were associated with a lower risk of suicidal thoughts in teens with obesity, a new study found.

Find out more about five biomimicry companies harnessing nature’s wisdom to create drug candidates for the benefit of human ...

My own experience initially led me to believe that weight loss was just a matter of commitment and a modicum of self-control.

PS makes wellness more accessible through real-life stories, first-person perspectives, and expert-backed information. Our ...

The $200B GLP-1 market is set to expand with 16 new obesity drugs launching by 2029, challenging Novo Nordisk and Eli Lilly's ...

Danish biotech Zealand Pharma is targeting the "next generation" of weight loss drugs as competitors pile into a market ...

There’s a war brewing over blockbuster weight loss medications — and patients are now getting caught in the crossfire.

The pharmaceutical industry has seen a tremendous surge in the development of weight loss drugs, particularly GLP-1 receptor ...

These two pharmaceutical giants are positioned for growth with their innovative diabetes and obesity treatments.

Medicare is prohibited by law from covering GLP-1 drugs for weight loss. But many beneficiaries can access the drugs anyway.